Veravas, Inc. - Company Market Research Report

Company Overview

• Name: Veravas, Inc.

• Mission: Making early disease detection possible through innovative diagnostics solutions.

• Founded: 2017

• Founders: No information is available.

• Key People:

• John Forrest, Co-Founder, CEO, & Executive Chairman

• Josh Soldo, Chief Scientific Officer & Co-Founder

• Luc Vanhal, Chief Operating Officer

• Chris Mirro, Chief Growth Officer

• Headquarters: 111 Congress Avenue, Suite 500, Austin, TX 78701

• Research & Development: 3510 Hopkins Place N, Oakdale, MN 55128

• Number of Employees: 11-50

• Revenue: No information is available.

• Known For: Transforming laboratory diagnostics through its proprietary VeraBIND™ technology, enabling early detection, especially for neurodegenerative diseases.

Products

VeraBIND Technology

• Description: Transformative technology designed to detect and analyze low-abundance biomarkers, enhancing precision and reliability in diagnostics.

• Key Features:

• Uniform Size Magnetic Nanobeads: Enhance reproducibility and accuracy.

• Hydrophilic Surface Layer: Increases sensitivity by reducing non-specific binding.

• Rapid Magnetic Separation: Improves laboratory efficiency.

Product Line

• VeraBIND Tau Assay:

• Description: A groundbreaking blood test for detecting tau pathology related to Alzheimer's disease.

• Key Features: Early detection of tau protein, enhancing diagnostic capabilities and supporting Alzheimer's research.

• VeraBIND Clean Beads Kit:

• Key Features: Removes human immunoglobulin interferences in samples.

• Streptavidin Beads for Free Biotin Depletion Kit:

• Key Features: Eliminates free biotin interference in assays.

• Streptavidin Beads Protein Coating Kit:

• Key Features: Allows creation of custom Capture Beads with biotinylated antibodies or antigens.

• Biomarker Purification Kit:

• Key Features: Captures and purifies biomarkers from various sample types.

• Antibody Detection Kit:

• Key Features: Detects human IgG, IgM, and IgA antibodies, enhancing immunoassay performance.

• Borrelia Antibody Assay:

• Key Features: Detects antibodies against Borrelia burgdorferi, pertinent to Lyme disease.

• tTG Antibody Assay:

• Key Features: Designed for celiac disease diagnostics by detecting antibodies against human tissue transglutaminase.

Recent Developments

• New Products Launched:

• VeraBIND Tau Assay for the early detection of Alzheimer's tau pathology.

• New Features Added: No information is available.

• New Partnerships:

• Collaboration with Phanes Biotech to develop the Tao pathology test, crucial for Alzheimer's detection.

• Scientific Publications:

• Demonstrated VeraPrep's effectiveness in neutralizing biotin interference.

Contact Information

• Phone: (512) 837-2827

• Email: info@veravas.com

• Website: [veravas.com](http://www.veravas.com)

Headquarters Location

• 111 Congress Avenue, Suite 500, Austin, TX 78701, USA

Research & Development Site

• 3510 Hopkins Place N, Oakdale, MN 55128, USA

Events and Engagements

• Upcoming participation in key conferences related to neurodegenerative diseases and Alzheimer's diagnosis.

This report presents Veravas, Inc. as a forward-thinking company leveraging its VeraBIND™ technology for substantial advancements in diagnostic accuracy. Through its strategic leadership and innovative solutions, Veravas is contributing significantly to early disease detection, particularly in the realm of neurodegenerative diseases such as Alzheimer’s.